Related Experiment Videos
p53, mdm-2, and p21 waf-1 in the porokeratoses
1Department of Pathology, University of South Florida College of Medicine, Tampa, USA.
Abstract:
The etiology of the porokeratoses is unknown. Overexpression of the p53 tumor suppressor protein and disregulated cell cycle control have been pathogenically implicated. The p53 tumor suppressor gene product is regulated by mdm2 and both gene products influence cell cycle progression through the cyclin-dependent kinase inhibitor p21. Thirty-three cases of the various types of porokeratosis were immunohistochemically studied for p53, mdm2, and p21 proteins. Each of the cases showed increased p53 and decreased mdm2 and p21 expression within keratinocytes underlying cornoid lamella. This study confirms the previous findings of increased p53 staining and expands the potential roles of mdm2 and p21 in the pathogenesis of the porokeratoses.
Insights
The exact cause of porokeratosis remains unknown, but this study found increased p53 protein and decreased mdm2 and p21 expression in affected skin cells, suggesting their role in disease development.
Area of Science:
- Dermatology
- Molecular Biology
- Oncology
Background:
- The etiology of porokeratoses is currently unknown.
- Overexpression of the p53 tumor suppressor protein and disrupted cell cycle regulation are suspected factors.
- p53, mdm2, and p21 are key regulators of cell cycle progression.
Purpose of the Study:
- To investigate the expression of p53, mdm2, and p21 proteins in various types of porokeratosis.
- To further elucidate the role of these proteins in the pathogenesis of porokeratoses.
Main Methods:
- Immunohistochemical analysis was performed on 33 cases of porokeratosis.
- Expression levels of p53, mdm2, and p21 proteins were assessed in keratinocytes underlying the cornoid lamella.
Main Results:
- All 33 cases exhibited increased p53 protein expression.
- Decreased expression of mdm2 and p21 proteins was observed in the affected keratinocytes.
- These findings confirm prior observations of elevated p53 staining.
Conclusions:
- The study supports the involvement of p53 in porokeratosis pathogenesis.
- The altered expression of mdm2 and p21 suggests they play a significant role in the disease.
- Further research into these molecular pathways may reveal therapeutic targets.